Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $486.64 | 33 | 84.7% |
| Education | $88.19 | 6 | 15.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $258.50 | 20 | $0 (2021) |
| AMAG Pharmaceuticals, Inc. | $67.09 | 5 | $0 (2019) |
| Roche Diagnostics Corporation | $64.94 | 3 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $54.18 | 4 | $0 (2021) |
| Exeltis, USA Inc. | $32.43 | 2 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $24.32 | 1 | $0 (2023) |
| CSL Behring | $21.10 | 1 | $0 (2018) |
| Sumitomo Pharma America, Inc. | $19.63 | 1 | $0 (2024) |
| Avion Pharmaceuticals | $17.54 | 1 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $15.10 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.41 | 2 | Sumitomo Pharma America, Inc. ($19.63) |
| 2023 | $41.97 | 2 | MAYNE PHARMA COMMERCIAL LLC ($24.32) |
| 2021 | $144.69 | 12 | AbbVie Inc. ($114.60) |
| 2020 | $83.85 | 5 | AbbVie Inc. ($32.62) |
| 2019 | $118.53 | 8 | AbbVie, Inc. ($86.58) |
| 2018 | $105.32 | 7 | AMAG Pharmaceuticals, Inc. ($31.10) |
| 2017 | $46.06 | 3 | AMAG Pharmaceuticals, Inc. ($23.86) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/12/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: HORMONE THERAPY | ||||||
| 12/05/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Oral Contraceptive | ||||||
| 04/12/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $24.32 | General |
| 11/16/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: WOMENS HEALTH | ||||||
| 10/26/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: WOMENS HEALTH | ||||||
| 09/30/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: WOMENS HEALTH | ||||||
| 08/10/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: WOMENS HEALTH | ||||||
| 06/08/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: WOMENS HEALTH | ||||||
| 05/27/2021 | Avion Pharmaceuticals | Balcoltra (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Oral Contraceptive | ||||||
| 05/21/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: WOMENS HEALTH | ||||||
| 05/13/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: WOMENS HEALTH | ||||||
| 04/23/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: WOMENS HEALTH | ||||||
| 04/20/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: WOMENS HEALTH | ||||||
| 03/04/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: WOMENS HEALTH | ||||||
| 01/19/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: WOMENS HEALTH | ||||||
| 10/21/2020 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: WOMENS HEALTH | ||||||
| 09/22/2020 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: WOMENS HEALTH | ||||||
| 08/19/2020 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL 9 | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: WOMENS HEALTH | ||||||
| 03/03/2020 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Women's Health | ||||||
| 01/22/2020 | Roche Diagnostics Corporation | RS Harmony Test Related Products (Device) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Sequencing | ||||||
| 11/06/2019 | Roche Diagnostics Corporation | RS Harmony Test Related Products (Device) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Sequencing | ||||||
| 08/22/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Endocrinology | ||||||
| 07/23/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Endocrinology | ||||||
| 06/18/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug), MAKENA | Education | In-kind items and services | $12.13 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 229 | 308 | $19,229 | $10,492 |
| 2022 | 8 | 266 | 370 | $29,173 | $15,119 |
| 2021 | 12 | 348 | 434 | $31,373 | $16,885 |
| 2020 | 11 | 370 | 469 | $32,849 | $15,677 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 132 | $12,672 | $6,565 | 51.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 45 | 45 | $2,610 | $1,603 | 61.4% |
| G0144 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision | Office | 2023 | 25 | 25 | $1,675 | $1,077 | 64.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 20 | $1,160 | $701.93 | 60.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 16 | 16 | $240.00 | $220.50 | 91.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $224.00 | $205.80 | 91.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 54 | $648.00 | $118.80 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 198 | $19,008 | $10,452 | 55.0% |
| G0144 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision | Office | 2022 | 41 | 41 | $2,747 | $1,705 | 62.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 15 | 19 | $3,686 | $1,368 | 37.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,680 | $604.89 | 36.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 17 | $986.00 | $476.39 | 48.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 14 | $210.00 | $206.10 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $196.00 | $192.36 | 98.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 36 | 55 | $660.00 | $113.55 | 17.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 194 | $18,624 | $10,383 | 55.8% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 13 | 19 | $3,686 | $1,524 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $1,540 | $939.76 | 61.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 25 | 25 | $1,450 | $890.50 | 61.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $1,680 | $889.33 | 52.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 28 | $1,624 | $855.14 | 52.7% |
| G0144 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision | Office | 2021 | 17 | 17 | $1,139 | $738.52 | 64.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 14 | 14 | $210.00 | $210.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $196.00 | $196.00 | 100.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 53 | 66 | $792.00 | $146.15 | 18.5% |
About Dr. John Shields, MD
Dr. John Shields, MD is a Obstetrics & Gynecology healthcare provider based in West Point, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023074101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Shields, MD has received a total of $574.83 in payments from pharmaceutical and medical device companies, with $34.41 received in 2024. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($486.64).
As a Medicare-enrolled provider, Shields has provided services to 1,213 Medicare beneficiaries, totaling 1,581 services with total Medicare billing of $58,173. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location West Point, MS
- Active Since 04/26/2006
- Last Updated 02/26/2011
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1023074101
Products in Payments
- Orilissa (Drug) $111.28
- ORIAHNN (Drug) $91.38
- INTRAROSA (Drug) $67.09
- RS Harmony Test Related Products (Device) $64.94
- NEXPLANON (Drug) $54.18
- LO LOESTRIN FE (Drug) $34.85
- SLYND (Drug) $32.43
- Rhophylac (Biological) $21.10
- ORILISSA (Drug) $20.99
- MYFEMBREE (Drug) $19.63
- Balcoltra (Drug) $17.54
- Kyleena (Drug) $15.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in West Point
Dr. Barbrette Clayborn, M.d, M.D
Obstetrics & Gynecology — Payments: $8,410
Cherita Brown
Obstetrics & Gynecology — Payments: $930.17
Timothy Whittle, Md, MD
Obstetrics & Gynecology — Payments: $367.13
Dr. Dian Kinch, M.d, M.D
Obstetrics & Gynecology — Payments: $97.34
Charlotte Magnussen, M.d, M.D
Obstetrics & Gynecology — Payments: $54.48
Dr. Amy Yavorek, Md, MD
Obstetrics & Gynecology